MD Clarity

What can we expect from healthcare MSO buyout activity through the end of 2024? It depends… Jerome Powell just signaled that the Fed is prepared to start cutting interest rates, and economists are predicting that the Fed will drop rates by 75 basis points in total through the end of the year. While a decline in interest rates is likely welcome news for MSO operators and their sponsors, a mid-four-percent Federal Funds rate is a far cry from the low interest rate environment that helped facilitate the scaling of many MSOs in 2021 and 2022. Despite overarching macroeconomic dynamics, MSO deal activity is likely to vary by category: ▪MSOs in the nascent cardiovascular space haven’t been slowed by the high interest rate environment. There were a record 20 cardiovascular MSO deals in 2023 (seven platform investments and 13 add-ons). About 80 percent of cardiovascular MSOs are less than three years old. Groups in less mature specialties benefit from a large amount of whitespace for both platform investment and rollup activity, which is likely to continue. ▪Meanwhile, the median hold time for MSOs in more mature specialties like eyecare, urgent care, and nephrology is more than five years. PE sponsors are grappling with prolonged hold periods and the desire for liquidity among LPs. It’s possible that the potential 75 basis point dip in interest rates can jar these platforms loose. Absent further rate reductions, we expect the next wave of platform buyers to be sponsors with the ability to underwrite and then deliver on value creation opportunities specific to organic growth and margin expansion. These value creation levers require revenue cycle and managed care contracting teams that are strong at mitigating denials, recovering underpayments, and negotiating high-performing contracts with payers. The MD Clarity team is energized by the MSOs and their sponsors that understand that operational rigor is the path to value creation in this economic environment. Unless rates return to near-zero, operational excellence as a priority is likely here to stay. #RevenueCycle #RCM #healthtech

We’re thrilled to announce MD Clarity has been recognized on the Inc. 5000 list of the fastest-growing private companies in America, coming in at No. 3587! This recognition highlights our rapid growth and our impact improving revenue cycle outcomes, streamlining patients’ financial experience, and reducing the administrative burden on staff. “This accomplishment is a testament to our team’s dedication to empowering Management Services Organizations (MSOs) and large physician-owned groups with our revenue optimization software. By addressing the complex financial challenges faced by these organizations, we’ve been able to drive significant growth while delivering exceptional results for providers and the patients they serve.” —Dan Freeman, MD Clarity CEO Read the full press release: https://lnkd.in/g4RcZvw3

MD Clarity has been named High Performer in G2’s Summer 2024 Report! MD Clarity earned a total of five awards under G2’s RCM Software category, including: ▪ High Performer ▪ Best Support ▪ Best Relationship ▪ Easiest To Do Business With ▪ Best Meets Requirements. “Our G2 High Performer recognition affirms the substantial impact our product has on both provider reimbursement and patient financial experience,” said Dan Freeman, MD Clarity’s CEO. Read the full press release: https://lnkd.in/gvKW6uKS

We’re excited to be in Las Vegas for the Healthcare Financial Management Association (HFMA) Annual Conference! Visit booth #644 to enter our raffle and learn how MD Clarity can help provider organizations accelerate cash flow and get paid in full.

We’re thrilled to sponsor the Healthcare Financial Management Association (HFMA) Annual Conference in Las Vegas next week! Stop by Booth #644 to see how MD Clarity can help providers get paid in full and accelerate patient cash flow.

We're excited to announce MD Clarity has joined the ModMed synapSYS Marketplace! MD Clarity’s application enables pre-service patient cost estimates and deposits, detects variances between payer payments and contracted rates, and provides data to negotiate managed care contracts from a position of strength. Read the full press release: https://lnkd.in/g6g9uFXn

We're thrilled to announce MD Clarity has joined the athenahealth Marketplace! MD Clarity’s integration optimizes revenue for healthcare providers, enabling pre-service patient cost estimates and deposits, detecting payment variance, and providing data to negotiate better managed care contracts. “Partnering with athenahealth enables a seamless experience for providers to ensure they are being paid optimally for all of their patient encounters and are delivering a transparent financial experience to patients.” — Dan Freeman, MD Clarity CEO Read the full press release: https://lnkd.in/gWqErKdF

We’re thrilled to be in Chicago for the American Alliance of Orthopaedic Executives (AAOE) Conference! Come visit us at booth #1028 to enter our giveaway and learn how MD Clarity can help your orthopedic practice get paid in full.

We’re excited to sponsor the American Alliance of Orthopaedic Executives (AAOE) Conference this week! Meet us at Booth #1028 to learn how MD Clarity can help orthopedic practices accelerate cash flow and get paid in full. Schedule a meeting at AAOE: https://lnkd.in/gcaZAiJj

Awesome opportunity to partner closely with CPO Mike Albainy and the broader MD Clarity product team in supercharging the value Clarity Flow and RevFind deliver every day for providers and the patients they serve.